University of California San Francisco School of Medicine: Department of Dermatology
Welcome,         Profile    Billing    Logout  
 9 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wofsy, David
VIBRANT, NCT05201469: VIB4920 for Active Lupus Nephritis

Recruiting
2
74
US
VIB4920, Placebo for VIB4920
National Institute of Allergy and Infectious Diseases (NIAID)
Lupus Nephritis
08/26
03/27
NCT03239470: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Terminated
1
5
US
Cohort 1: 1.0 x 10^8 PolyTregs, Polyclonal Regulatory T Cells, autologous PolyTregs, CD4+CD127lo/negCD25+ PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Pemphigus Foliaceus, Pemphigus Vulgaris
12/20
01/23
Bluestone, Jeffrey A
NCT03239470: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Terminated
1
5
US
Cohort 1: 1.0 x 10^8 PolyTregs, Polyclonal Regulatory T Cells, autologous PolyTregs, CD4+CD127lo/negCD25+ PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Pemphigus Foliaceus, Pemphigus Vulgaris
12/20
01/23
Haemel, Anna
NCT03239470: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Terminated
1
5
US
Cohort 1: 1.0 x 10^8 PolyTregs, Polyclonal Regulatory T Cells, autologous PolyTregs, CD4+CD127lo/negCD25+ PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Pemphigus Foliaceus, Pemphigus Vulgaris
12/20
01/23
Rosenblum, Michael
NCT03239470: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Terminated
1
5
US
Cohort 1: 1.0 x 10^8 PolyTregs, Polyclonal Regulatory T Cells, autologous PolyTregs, CD4+CD127lo/negCD25+ PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Pemphigus Foliaceus, Pemphigus Vulgaris
12/20
01/23
Naik, Haley
NCT03239470: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Terminated
1
5
US
Cohort 1: 1.0 x 10^8 PolyTregs, Polyclonal Regulatory T Cells, autologous PolyTregs, CD4+CD127lo/negCD25+ PolyTregs, Cohort 2: 2.5x10^8 PolyTregs
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Pemphigus Foliaceus, Pemphigus Vulgaris
12/20
01/23
NCT03967600: Clinical and Biological Characteristics of Hidradenitis Suppurativa

Recruiting
N/A
1000
US
University of California, San Francisco
Hidradenitis Suppurativa
07/26
07/26
HS PROGRESS, NCT04115566: Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Recruiting
N/A
3000
US
University of California, San Francisco
Hidradenitis Suppurativa
01/30
01/30
Espino, Lidia
TOP-CKD, NCT04258397: Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease

Recruiting
2
200
US
Pirfenidone, ESBRIET, matching placebo
Veterans Medical Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), San Diego Veterans Healthcare System, University of California, San Diego, University of California, San Francisco, Genentech, Inc.
Chronic Kidney Disease
05/24
12/24
VIBRANT, NCT05201469: VIB4920 for Active Lupus Nephritis

Recruiting
2
74
US
VIB4920, Placebo for VIB4920
National Institute of Allergy and Infectious Diseases (NIAID)
Lupus Nephritis
08/26
03/27
Pidlaoan, Rowela
No trials found

Download Options